Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127236672 | 12723667 | 2 | F | 2011 | 20160913 | 20160908 | 20160927 | EXP | BR-EMD SERONO-7207180 | EMD SERONO INC | 0.00 | F | Y | 0.00000 | 20160927 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127236672 | 12723667 | 1 | PS | REBIF | INTERFERON BETA-1A | 1 | Subcutaneous | U | 103780 | 22 | UG | INJECTION | TIW | ||||||
| 127236672 | 12723667 | 2 | SS | REBIF | INTERFERON BETA-1A | 1 | Subcutaneous | U | 103780 | 44 | UG | INJECTION | TIW | ||||||
| 127236672 | 12723667 | 3 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | 0 | ||||||||||||
| 127236672 | 12723667 | 4 | C | FLUIMICIL | ACETYLCYSTEINE | 1 | 0 | ||||||||||||
| 127236672 | 12723667 | 5 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 127236672 | 12723667 | 6 | C | VITAMIN E /00110501/ | TOCOPHEROL | 1 | 0 | ||||||||||||
| 127236672 | 12723667 | 7 | C | LINSEED /01649402/ | 2 | 0 | |||||||||||||
| 127236672 | 12723667 | 8 | C | MANTIDAN | AMANTADINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127236672 | 12723667 | 9 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 127236672 | 12723667 | 10 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127236672 | 12723667 | 1 | Relapsing-remitting multiple sclerosis |
| 127236672 | 12723667 | 3 | Product used for unknown indication |
| 127236672 | 12723667 | 4 | Product used for unknown indication |
| 127236672 | 12723667 | 5 | Product used for unknown indication |
| 127236672 | 12723667 | 6 | Product used for unknown indication |
| 127236672 | 12723667 | 7 | Product used for unknown indication |
| 127236672 | 12723667 | 8 | Product used for unknown indication |
| 127236672 | 12723667 | 9 | Product used for unknown indication |
| 127236672 | 12723667 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127236672 | 12723667 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127236672 | 12723667 | Arthralgia | |
| 127236672 | 12723667 | Cataract | |
| 127236672 | 12723667 | Macular hole | |
| 127236672 | 12723667 | Malaise | |
| 127236672 | 12723667 | Ocular vascular disorder | |
| 127236672 | 12723667 | Pain | |
| 127236672 | 12723667 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127236672 | 12723667 | 1 | 20020503 | 0 |